Global Settlement for About 500 Androderm Cases by Actavis
Global Settlement for About 500 Androderm Cases by Actavis
Introduction
A case management order issued by Judge Matthew Kennelly on June 29, confirmed that Actavis has agreed to settle all Androderm lawsuits filed by men claiming they suffered a heart attack, stroke or other injuries as side effects of their testosterone replacement therapy (TRT) drug. As per the order, about 500 of the testosterone claims pending in the multidistrict litigation (MDL 2545; In Re: Testosterone Replacement Therapy Products Liability Litigation) involve Androderm.
Though no potential settlement order has been released, Judge Kennelly cited putting a stay on all Androderm claims against Actavis would allow parties to dedicate time and energy to finalize the agreement. The first bellwether trial date (August 6, 2018) for Androderm lawsuits has not been vacated yet.
Testosterone Replacement Therapy lawsuits are centralized before U.S. District Judge Matthew Kennelly in the Northern District of Illinois as a part of a federal multidistrict litigation (MDL No. 2545; In Re: Testosterone Replacement Therapy Products Liability Litigation).
Comments
Latest News
New Front Emerges in Fight Against Synthetic Opioids
Categories: Opioids
The U.S. opioid crisis has already claimed hundreds of thousands of lives, with fentanyl standing out as one of the deadliest substances. Now the leading cause of death among Americans aged 18 to 44, fentanyl has become synonymous with overdose…
Exactech to Pay $8M to Settle Defective Knee Implant Suit
Categories: Attune Knee System
Medical device maker Exactech has agreed to an $8 million settlement to resolve allegations that it hid defects in a widely used line of artificial knee implants.
The implants have been linked to thousands of patient injuries and sparked…
Talcum Powder Cancer Settlement Talks Begin Sept. 4
Categories: Talcum
Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…